Daito Chemix (4366) · FactSignificant increase in full-year comprehensive income
Increase in interim comprehensive income due to valuation differences on other securities
First written in FY2026-H1. . Latest entry: FY2026.
3entries
2years
1from disclosures
How it moved
Same theme, other companies
Changes in Net Assets, Valuation Differences, etc.A theme 68 companies write about · 33 as a headwind · 26 as a tailwind
The whole theme swung hardest in 2022: 10 of 55 companies on the "Worse" side.
39 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 68 companies compared. The sentences above are computed from all 68.Full recordFilings, disclosures and news, newest first
- FY2026Significant increase in full-year comprehensive incomeAnnual report
「包括利益 426 1,621」
包括利益は前年の426百万円から1,621百万円へ増加した。その他有価証券評価差額金697百万円、退職給付に係る調整額111百万円等がその他の包括利益の増加要因となった。 - 2026-05-11OtherRevisions to earnings forecasts
「Comprehensive income 426 1,621」
Comprehensive income increased from ¥426 million in the previous consolidated fiscal year to ¥1.621 billion in the current consolidated fiscal year. - FY2026-H1First statedAnnual report
「中間包括利益は、662百万円（前年同期は8百万円）となりました。その他有価証券評価差額金398百万円、持分法適用会社に対する持分相当額41百万円、繰延ヘッジ損益12百万円」
中間包括利益は前年同期の8百万円から662百万円へ増加した。その他有価証券評価差額金、持分法適用会社に対する持分相当額、繰延ヘッジ損益がその他の包括利益の増加要因として記載されている。